December 16, 2016 6:30pm
At the end of the session, traders closed, rolled out and offset their expiring positions
The stem, cell, gene and regenerative therapy (SCG&RT) sector opened positive, was barely positive at the mid-day and closed negative.
Pre-open indication’s tally: 2 hits (BSTG and VCEL) and 4 miss (BCLI, KITE, SGMO and XON)
There are two things that investors need - interpretation of news and translation of market metrics concerning the stem, cell, gene and regenerative therapy sector to substantiate share pricing.
I answer one question; in which company should investors put, keep and commit their money!
I say today what others won't, so you can do what others can't!
U.S. stocks closed slightly lower Friday, with financials lagging, following some renewed concern of geopolitical tension.
The NASDAQ closed DOWN -19.69 or -0.36% to 5,437.16 and the DOW closed DOWN -8.83or -0.04% to 19,843.41.
A day in the life of the stem, cell, gene and regenerative therapy (SCGT & RT) sector – the advance/decline line scenario of our 43 covered companies:
- The open was positive with an A/DL of 23/16 and 4 flats;
- The mid-day was barely positive with an A/DL of 21/19 and 3 flats;
- The closing bell dumped negative with A/DL of 14/26 and 3 flats;
Henry’omics:
The stem, cell, gene and regenerative therapy (SCG&RT) sector opened positive, stayed but, barely positive at the mid-day and closed negative.
- From this morning’s investor’s letter, “Triple witching Friday … these opportunities are the catalysts for heavy volume and many downdrafts going into the close on triple witching days, as traders attempt to profit on small price imbalances with large round-trip trades that may be completed in seconds.”
Option’s expiration made the session crash … as the SCG&RT sector gave up … opening gains to close negative, having opened with a positive with the Nasdaq the worst performer, down over a third of a percent and closed almost the direct opposite of the advance/decline lines.
The iShares Russell 2000 (IWM) indicated a positive pre- open of +0.33% and closed DOWN -0.18%; the iShares NASDAQ Biotechnology (IBB) indicate positive +0.76% in the pre-open and closed UP +0.18%.
- The CBOE Volatility Index (VIX), widely considered the best gauge of fear in the market, traded lower near 12.2.
Today’s 3 biggest $ gainers included:
- Kite Pharma (KITE) +$2.49 after Thursday’s +$1.64 after Wednesday’s +$1.02;
- Juno Therapeutics (JUNO) +$0.31 after Thursday’s +0.75;
- uniQure (QURE) +$0.26
Today’s 3 biggest $ losers of the session were:
- MiMedx (MDXG) -$0.59;
- Applied Genetic technologies (AGTC) -$0.50 after Thursday’s -$0.20;
- Vericel (VCEL) -$0.45 after Thursday’s-$0.60 after Wednesday’s +$1.50;
The downside trend reflects a pricing trend range of:
- Friday’s decliners ranged from -0.07% <BLUE> to -19.36% <NWBO> in 26 equities;
- Thursday’s decliners ranged from -0.11% <MDXG> to -15.06% <NWBO>in 19 equities;
- Wednesday’s decliners ranged from -0.22% <MDXG> to- 7.36% <IMUC> in 26 equities;
- Tuesday’s decliners ranged from -0.64% <CYTX> to -14.19% <ISCO> in 19 equities;
- Monday’s decliners ranged from -0.00% <BCLI> to -19.83% <OPXA> in 27 equities;
The upside shows a pricing trend range of:
- Friday’s gainers ranged from +0.09% <ONCE> to +10.42% <CYTX> in 14 equities;
- Thursday’s gainers ranged from +0.28% <VTGN> to +14.22% <BSTG> in 22 equities;
- Wednesday’s gainers ranged from +0.08% <ONCE> to +57.69% <VCEL> in 16 equities
- Tuesday’s gainers ranged from +0.63% to +10.80% in 22 equities;
- Monday’s gainers ranged from +0.63% <CLLS> to +12.29% <CUR> in 14 equities;
Wrap-up: anybody can read a paragraph … review the percentage changes per day in the week of the decliners and advancers while …
- Monday’s 14 gainers compared to Tuesday’s 22 and was followed by Wednesday’s 16, Thursday’s 23 and Friday’s 26
- Monday’s 27 decliners compared to Tuesday’s 19 and was followed by Wednesday’s 26, Thursday’s 19 and Friday’s 14
Pre-open indication’s tally: 2 hits (BSTG and VCEL) and 4 miss (BCLI, KITE, SGMO and XON)
- Biostage (BSTG) closed DOWN -$0.0085 – hit;
- Brainstorm Cell Therapeutics (BCLI) closed UP +$0.19 – miss;
- Intrexon (XON) closed UP +$0.03 – miss;
- Kite Pharma (KITE) closed UP +$2.49 – miss;
- Sangamo (SGMO) closed UP +$0.25 – miss;
- Vericel (VCEL) closed DOWN -$0.45 – hit;
Percentage (%) decliners:
- Northwest Bio (NWBO) -19.36% after Thursday’s -15.06% after Wednesday’s +21.17% after Tuesday’s +10.66% after Monday’s +3.17%;
- Vericel (VCEL) -12.86% after Thursday’s -14.63% after Wednesday’s +57.69%;
- International Stem Cell (ISCO) -11.76% after Thursday’s -6.21% after Wednesday’s +9.02% after Tuesday’s -14.19% after Monday’s -7.74%;
- MiMedx (MDXG) -6.43%
- Mesoblast (MESO)-5.89%
Percentage (%) advancers:
- Cytori (CYTX) +10.42%;
- Brainstorm (BCLI) +7.66%;
- Sangamo (SGMO) +7.35%
- BioTime (NYSEMKT: BTX) +5.88%;
- Asterias Biotherapeutics (NYSEMKT: AST) +5.68%
Flat:
- Athersys (ATHX) at $1.59;
- Osiris (OSIR) at $4.95;
- ReNeuron (RENE.L) at $2.625
Review my fear gauge or the CBOE Volatility Index (VIX):
· Friday traded near 12.2;
· Thursday traded near 12.7;
· Wednesday traded near 13.4;
· Tuesday traded near 12.7;
· Monday traded near 12.64;
· Friday traded near 11.8;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
